Correlation Between International Biotechnology and Impax Asset

Can any of the company-specific risk be diversified away by investing in both International Biotechnology and Impax Asset at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining International Biotechnology and Impax Asset into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between International Biotechnology Trust and Impax Asset Management, you can compare the effects of market volatilities on International Biotechnology and Impax Asset and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in International Biotechnology with a short position of Impax Asset. Check out your portfolio center. Please also check ongoing floating volatility patterns of International Biotechnology and Impax Asset.

Diversification Opportunities for International Biotechnology and Impax Asset

0.49

Correlation Coefficient

International Biotechnology  Impax Asset

Very weak diversification

The 3 months correlation between International and Impax is 0.49. Overlapping area represents the amount of risk that can be diversified away by holding International Biotechnology Tr and Impax Asset Management in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Impax Asset Management and International Biotechnology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on International Biotechnology Trust are associated (or correlated) with Impax Asset. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Impax Asset Management has no effect on the direction of International Biotechnology i.e., International Biotechnology and Impax Asset go up and down completely randomly.

Pair Corralation between International Biotechnology and Impax Asset

Assuming the 90 days trading horizon International Biotechnology is expected to generate 4.53 times less return on investment than Impax Asset. But when comparing it to its historical volatility, International Biotechnology Trust is 1.37 times less risky than Impax Asset. It trades about 0.09 of its potential returns per unit of risk. Impax Asset Management is currently generating about 0.3 of returns per unit of risk over similar time horizon. If you would invest  13,550  in Impax Asset Management on April 24, 2025 and sell it today you would earn a total of  7,150  from holding Impax Asset Management or generate 52.77% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

International Biotechnology Tr  vs.  Impax Asset Management

International Biotechnology

Risk-Adjusted Performance

OK

Compared to the overall equity markets, risk-adjusted returns on investments in International Biotechnology Trust are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. In spite of rather uncertain technical and fundamental indicators, International Biotechnology may actually be approaching a critical reversion point that can send shares even higher in August 2025.

Impax Asset Management

Risk-Adjusted Performance

Solid

Compared to the overall equity markets, risk-adjusted returns on investments in Impax Asset Management are ranked lower than 23 (%) of all global equities and portfolios over the last 90 days. In spite of rather uncertain technical and fundamental indicators, Impax Asset exhibited solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with International Biotechnology and Impax Asset

The main advantage of trading using opposite International Biotechnology and Impax Asset positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if International Biotechnology position performs unexpectedly, Impax Asset can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Impax Asset will offset losses from the drop in Impax Asset's long position.

The idea behind International Biotechnology Trust and Impax Asset Management pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stock Screener module to find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook..